These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 28274403)
1. Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experience. Buscariollo DL; Drumm M; Niemierko A; Clayman RH; Galland-Girodet S; Rodin D; Feldman AS; M Dahl D; McGovern FJ; F Olumi A; Eidelman A; Shipley WU; Zietman AL; Efstathiou JA Pract Radiat Oncol; 2017; 7(2):e125-e133. PubMed ID: 28274403 [TBL] [Abstract][Full Text] [Related]
2. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Briganti A; Wiegel T; Joniau S; Cozzarini C; Bianchi M; Sun M; Tombal B; Haustermans K; Budiharto T; Hinkelbein W; Di Muzio N; Karakiewicz PI; Montorsi F; Van Poppel H Eur Urol; 2012 Sep; 62(3):472-87. PubMed ID: 22633803 [TBL] [Abstract][Full Text] [Related]
3. Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features. Hwang WL; Tendulkar RD; Niemierko A; Agrawal S; Stephans KL; Spratt DE; Hearn JW; Koontz BF; Lee WR; Michalski JM; Pisansky TM; Liauw SL; Abramowitz MC; Pollack A; Moghanaki D; Anscher MS; Den RB; Zietman AL; Stephenson AJ; Efstathiou JA JAMA Oncol; 2018 May; 4(5):e175230. PubMed ID: 29372236 [TBL] [Abstract][Full Text] [Related]
4. Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series. Fossati N; Karnes RJ; Boorjian SA; Moschini M; Morlacco A; Bossi A; Seisen T; Cozzarini C; Fiorino C; Noris Chiorda B; Gandaglia G; Dell'Oglio P; Joniau S; Tosco L; Shariat S; Goldner G; Hinkelbein W; Bartkowiak D; Haustermans K; Tombal B; Montorsi F; Van Poppel H; Wiegel T; Briganti A Eur Urol; 2017 Jun; 71(6):886-893. PubMed ID: 27484843 [TBL] [Abstract][Full Text] [Related]
5. Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival. Casas F; Valduvieco I; Oses G; Izquierdo L; Archila I; Costa M; Cortes KS; Barreto T; Ferrer F Clin Transl Oncol; 2019 Mar; 21(3):355-362. PubMed ID: 30128953 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes. Mishra MV; Scher ED; Andrel J; Margules AC; Hegarty SE; Trabulsi EJ; Hyslop T; Den RB; Lallas CD; Gomella LG; Dicker AP; Showalter TN Am J Clin Oncol; 2015 Feb; 38(1):55-60. PubMed ID: 24051934 [TBL] [Abstract][Full Text] [Related]
7. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features. Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249 [TBL] [Abstract][Full Text] [Related]
9. Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. Gutt R; Tonlaar N; Kunnavakkam R; Karrison T; Weichselbaum RR; Liauw SL J Clin Oncol; 2010 Jun; 28(16):2653-9. PubMed ID: 20421534 [TBL] [Abstract][Full Text] [Related]
10. Ten-Year Outcomes of Moderately Hypofractionated Salvage Postprostatectomy Radiation Therapy and External Validation of a Contemporary Multivariable Nomogram for Biochemical Failure. Chin S; Fatimilehin A; Walshaw R; Argarwal A; Mistry H; Elliott T; Logue J; Wylie J; Choudhury A Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):288-296. PubMed ID: 31987961 [TBL] [Abstract][Full Text] [Related]
11. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter? Hsu CC; Paciorek AT; Cooperberg MR; Roach M; Hsu IC; Carroll PR BJU Int; 2015 Nov; 116(5):713-20. PubMed ID: 25600860 [TBL] [Abstract][Full Text] [Related]
13. A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial. Pearse M; Fraser-Browne C; Davis ID; Duchesne GM; Fisher R; Frydenberg M; Haworth A; Jose C; Joseph DJ; Lim TS; Matthews J; Millar J; Sidhom M; Spry NA; Tang CI; Turner S; Williams SG; Wiltshire K; Woo HH; Kneebone A BJU Int; 2014 Mar; 113 Suppl 2():7-12. PubMed ID: 24894850 [TBL] [Abstract][Full Text] [Related]
15. The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysis. Tao R; Dai J; Bai Y; Yang J; Sun G; Zhang X; Zhao J; Zeng H; Shen P Radiat Oncol; 2019 Nov; 14(1):197. PubMed ID: 31706339 [TBL] [Abstract][Full Text] [Related]
16. Very Early Salvage Radiotherapy Improves Distant Metastasis-Free Survival. Abugharib A; Jackson WC; Tumati V; Dess RT; Lee JY; Zhao SG; Soliman M; Zumsteg ZS; Mehra R; Feng FY; Morgan TM; Desai N; Spratt DE J Urol; 2017 Mar; 197(3 Pt 1):662-668. PubMed ID: 27614333 [TBL] [Abstract][Full Text] [Related]
17. A comprehensive assessment of the prognostic utility of the Stephenson nomogram for salvage radiation therapy postprostatectomy. Johnson S; Jackson W; Speers C; Feng F; Hamstra D Pract Radiat Oncol; 2014; 4(6):422-9. PubMed ID: 25407865 [TBL] [Abstract][Full Text] [Related]
18. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies. Briganti A; Joniau S; Gandaglia G; Cozzarini C; Sun M; Tombal B; Haustermans K; Hinkelbein W; Shariat SF; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):960-7. PubMed ID: 24351411 [TBL] [Abstract][Full Text] [Related]
19. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457 [TBL] [Abstract][Full Text] [Related]